NCT00051337View on ClinicalTrials.gov

Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

January 31, 2005

Conditions
Hyperkinesis
Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00051337 - Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders | Biotech Hunter | Biotech Hunter